"Scan your face for three seconds, get your blood sugar": how a Vietnamese app factory sells a blood sugar log for $9.99 a week
What it is A blood sugar log app from BEGAMOB, part of Vietnam's iKame: you log glucose, insulin, meds and weight by hand, plus a "face scan" feature that can't actually read blood sugar. It sells as a $6.99–9.99 weekly subscription.
Why it took off Facebook video ads say "free, scan your face for three seconds with the front camera to check blood sugar" to pull in middle-aged and older diabetics. The first paywall shows the face-scan demo video and sells a weekly plan. Users get a rating prompt right after logging their first entry, which pushed the average to 4.7. The same company had already run this playbook on heart rate and blood pressure, and in early October it ramped up paid spend on both ends.
DHow you could copy it Don't. The core hook is a false medical claim, and the legitimate version is a decade-old, crowded category. Only borrow the tactics: a paywall built around a demo video, asking for a review right after the first core action, and launching a new app on an adjacent topic once one has worked. Apply them to a product that can actually deliver what it promises.
- Data (updated daily) · First launched 2026-08-31 · US rating 1,018 · Best overall Top Grossing rank #11-06 (VG) · Charted in 94 stores (11-06 countries) · 60
iOS · Top Grossing rank · by store VGNepalUGData 2026-10-28 → 2026-11-06 (10 days, 7 observations). Lower rank is higher; gaps mean it wasn't charted that dayiOS · Best category rank · US store Data 2026-10-28 → 2026-11-06 (10 days, 10 observations). Best rank across each day's category chartsiOS · Number of stores charted (top 200 on any chart) Data 2026-10-28 → 2026-11-06 (10 days, 8 observations)
Glucera is an ordinary blood sugar log: glucose, insulin, meds and weight, all entered by hand. On the US App Store it sells a $6.99–9.99 weekly subscription. Two months after launch it had 1,000+ ratings averaging 4.7. What drew people in was a line from its Facebook video ads: "Free. Scan your face with the front camera and check your blood sugar. No more finger pricks." The app can't do that. Below is how the playbook works, who's behind it, which half you can learn from, and which half to stay away from.
One video and one bad review on the same day
On the morning of Sep 2026, 25, a Facebook page called "Glucera - Blood Sugar Monitor" posted a Reel titled "Blood Sugar Tracking Made Simple." The caption was restrained: "Blood Sugar helps you log your numbers, spot patterns and understand trends." By early November, the video had 89k views and only 232 reactions and 16 comments. That much reach with that little engagement almost certainly means it was paid.
The same caption sits under at least seven or eight other videos on that page, but the spoken script says something else. Text indexed from the videos includes lines like: "Blood Sugar is a free app. Use the front camera to instantly measure your blood sugar. Stop pricking your finger every day. Open the app, hold the front camera to your face for three seconds, and you get an accurate..." In one video the voiceover even opens by naming another app from the same company, FaceVital. It's clearly one script with the name swapped.
Also in Sep 25, a 1-star review for Glucera showed up on the US App Store:
"I've downloaded several of this developer's apps. The Facebook ad shows someone scanning their face and getting a blood sugar reading right away. None of his apps can do that, and this one can't either. He calls it a 'blood sugar log' on the App Store, which tells you the ad is fake." JamieReneeH, US store, 9-25
What it is
The developer is BEGAMOB GLOBAL LIMITED, the publishing entity for iKame, an app company in Hanoi, Vietnam, which has 20+ apps under its name. Glucera hit iOS in 2026 Aug 31 and supports 33 languages. Its category is listed as Lifestyle, not Medical.
What it does once opened: manual logging of blood sugar, insulin, meds and weight, a red/yellow/green gauge based on readings, an estimated HbA1c, reminders, and report export. Long-established free logging tools already offer all of this, and more thoroughly.
The store page is careful: "This app does not measure or diagnose... The face scan is only a healthy lifestyle feature." The "scan your face to check blood sugar" claim from the ads appears nowhere on the page. The privacy policy is hosted at face-scan-privacy.begamob.com, the same domain used by FaceVital, the company's face-scan app. The "Face Scan" in Glucera is very likely carried over from FaceVital. What it actually outputs (heart rate, stress, or nothing at all) hasn't been verified by installing it.
How big it is now
| Metric | Metric |
|---|---|
| US iOS store rating | 10-28 is 887, and 11-06 is 1,018; 10–18 new ratings per day, averaging 4.67 |
| iOS global rating | 1,203, about 85% of them in the US, followed by Mexico, Australia and the Philippines |
| US Lifestyle Top Grossing chart | #10-28 at 55, then gradually fell to #11-06 at 75; never made the overall chart |
| Android installs | 8-21 launched; in all of September it had fewer than 100 installs. Starting 10-02 it suddenly scaled up. 10-03 is at 3,599 installs, 11-06 at 49,602, and over the last 7 days +12,362 |
| Pricing | Weekly subscription $9.99 / $6.99; annual subscription $49.99 / $39.99 / $29.99 |
(App Store US page and ratings, Google Play installs, as of 11-06)
The Android curve tells the story: almost nobody installed it in September, then in October 2 it was like someone turned on a tap. An app's organic demand doesn't go from zero to thousands in a day. Ad budget was switched on.
Revenue isn't public. Third-party estimates vary widely: ScreensDesign puts it at $35k a month and 30k installs a month, while other sources go as high as $100k or even $210k a month. Compared with the US Lifestyle Top Grossing chart at #55–75, a few thousand dollars a day in revenue is plausible (estimate). Treat it as an order of magnitude only.
How the money moves
The whole chain has four links, and each one is visible from the outside:
1. The ad says what the store page won't. The creative says "free, scan your face for three seconds for blood sugar, no finger pricks," aimed at middle-aged and older diabetics scrolling Facebook video. Tens of millions of Americans prick their fingers daily, so the line hits a nerve. At least two dedicated pages post these videos: "Glucera - Blood Sugar Monitor" and "Glucera - Friendly Blood Sugar Monitor." How many ads are running and how large the budget is can't be seen from outside (unverified).
2. The paywall picks up the ad's promise. ScreensDesign broke down its flow: a 12-step onboarding, a BMI calculation in the middle as a small reward, then the paywall right after. The paywall background is a full-screen video demonstrating face scanning, with one option below it: pay weekly. Users came for face scanning, saw a video of face scanning, and paid.
3. Ask for a review right after the first entry. The same teardown notes that once a user logs their first blood sugar reading and sees the colored gauge, the app shows a custom rating prompt. That's when the user is in the best mood. The result is 1,018 ratings averaging 4.67, but only 13 with text, and 10 of those are 1-star.
4. Keep the store page clean. It's filed under Lifestyle, the description includes a disclaimer, and the developer replies to bad reviews with one line: "Glucera is designed for blood sugar logging." The exaggerated claims only show up in the ads. That's how it passed review and stayed live (inference: avoiding the Medical category likely dodges the strict scrutiny Apple's App Review Guideline 1.4.1 gives to health measurement claims).
The 13 written reviews read like one story:
"The ad said it was free. Then when we had to enter our data, it wanted $9.99 a week. Outrageous." Nana1951,10-10
"The ad made it look like face scanning checks blood sugar, and that's why I bought it! It can't!" concurs, 10-08
"I asked to cancel and they kept charging me. There's no face-scan blood sugar reading at all." NayNay2023,10-01
"Facebook says it reads blood sugar and it doesn't. It tricks you into paying. $10 a week isn't worth it." ammnko, 10-20
The weekly subscription math is simple: even if someone cancels after two or three weeks, $20–30 already covers the cost of acquiring them. As long as the average rating holds up, more bad reviews won't stop the ads.
It's not the first, it's the fourth
BEGAMOB isn't building one blood sugar app. It's copying a model. iCardiac, a phone heart rate app from 2023, built up 31k ratings on the US store first and proved the "health measurement → weekly subscription" loop. In 2026 it then launched three new apps back to back:
| App | Launched | Topic | New US ratings over the last 7 days |
|---|---|---|---|
| FaceVital | 6-19 | Face-scan heart rate and stress | 124 |
| Artera | 8-23 | Blood pressure | 118 |
| Glucera | 8-31 | Blood sugar | 101 |
(US App Store, 11-06)
All three are in 33 languages, use the same pricing, and run the same ad script. It's the same health anxieties, swapped one at a time: heart rate, blood pressure, blood sugar. Even the ad scripts are mixed up.
It's not the only company doing this. Hong Kong's X-PIONEER has HealthPro: Blood Sugar (launched March) and X-SPARK has RateTracker (launched 2025), both of which say "measure heart rate with your phone, log blood sugar," adding ratings on the US store at roughly Glucera's pace. A Beijing company's MyVitalTrack launched in September and is also running Meta ads for "log blood pressure, blood oxygen and blood sugar." These "AI face-scan health" ads have been under scrutiny for a while: PhoneArena published "the biggest scam on the App Store today" in August 2024, the Diabetes Victoria association in Australia issued a warning, and TrendLife wrote a batch of pieces in October 2.
On the other side are the legitimate blood sugar tools: Roche's mySugr (33.6k US ratings, connects to glucose meters), Glucose | Blood Sugar Tracker from 2016 (28.6k ratings, #25 in Medical Top Grossing), and Glucose Buddy (24.6k). People on continuous glucose monitors just use the official Dexcom and Libre apps plus Apple Health. On Android, the top blood sugar apps have 25M installs, hundreds of times Glucera's.
One more note: there's also a separate, unrelated app called Glucera on the App Store (glucera.app, launched in April) that connects to Bluetooth glucose meters, writes to Apple Health, and works offline. The names collide, and it has nothing to do with BEGAMOB.
Has anyone noticed it?
Hardly. You can't find it on X, TikTok or Reddit, and no media outlet has written about it on its own (searching "Glucera" mostly returns Abbott's nutrition drink Glucerna). The only people who see it are those who get the Facebook ad, and those who download it and then go back to the App Store to leave a 1-star review.
But low awareness is not an opportunity here. The playbook is public, many companies run the same thing, and more and more people are calling it out.
If it were you
D Don't copy its approach. Its real hook, "face-scan blood sugar," is a false medical claim. Take that hook away and what's left is a decade-old, crowded category where Roche has medical credibility. What's worth borrowing is the paywall and the review-prompt tactics, not the business.
Who it fits: people already running health-logging apps who have an ad team, using it as a teaching case for conversion flows.
Who it doesn't fit: indie devs trying to build a new blood sugar app. Do it straight, and you're competing with mySugr and Glucose Buddy for search terms. Copy this one, and you're up against a factory that can churn out apps, runs in 33 languages, and operates several Facebook pages at once, all while carrying the risk of App Store removal and FTC attention (the FTC fined an app in 2016 for claiming it could measure blood pressure with a phone).
How to do it (only the half worth learning):
- Build the paywall around a demo video of the feature users most want, not a wall of text;
- Trigger your own review prompt at the moment the user completes the first core action (logs the first entry, sees the first result);
- Once a topic's creative and paywall work, launch a new app on an adjacent topic and reuse the same flow;
- The ad and the store page say the same thing: the feature is "record, remind, and a report for your doctor," and the ad only sells that.
How they get users: if you build a real logging tool, the people you target on Facebook are the same as Glucera's: middle-aged and older people with diabetes or prediabetes. The creative should push things the app actually delivers, like "one-tap export of a report for your doctor before your appointment" or "reminders when you forget your meds." Don't use "free" as the hook and then charge weekly on the first screen. That's the complaint that shows up most in the reviews.
Deadline: none. This isn't an opportunity with a window that closes.
What would prove this wrong: (1) Apple pulls Glucera or a similar BEGAMOB app, or the FTC or a US state attorney general goes after "scan your face to measure blood sugar" apps. That would mean the road is closed and there's no point studying it. (2) The reverse: if in three months Glucera's ads and store page only talk about logging, and it still averages more than 10 new US ratings a day, then "blood sugar logging + weekly subscription + paid acquisition" makes money by itself. The honest version would deserve another look and a one-grade bump.
Research notes: competitor table, acquisition evidence, full research report
- Competitors
Name Where Launched Scale How it differs from this one Glucose | Blood Sugar Tracker(App Sub 1 LLC) iOS 2016-07 US 28.6k ratings, Medical Top Grossing for 25,7 days +19 Long-running pure logging tool with no "scan to measure" gimmick, relies on organic search mySugr(Roche) iOS 2012-04 US 33.6k ratings, Medical Top Grossing for 50,7 days +80 Medical certification, connects to glucose meters, medical backing Glucose Buddy(Azumio) iOS 2008-10 US store 24.6k rating Established brand logging plus subscription, growth has mostly stalled HealthPro: Blood Sugar(X-PIONEER HK) iOS 2026-03 US 2,778 ratings, 7 days +118 Closest in approach (camera heart-rate reading plus blood sugar logging), leads with heart rate; rating growth about the same as Glucera RateTracker: Blood Sugar(X-SPARK HK) iOS 2025-06 US 5,645 ratings, 7 days +82 Same category, measures heart rate with the phone plus blood sugar logging, launched earlier Blood Sugar - Diabetes App and others Android Years About 25M installs, 7 days +200k The top same-category app on Android, several hundred times Glucera's scale Glucera (glucera.app, name collision) iOS 2026-04 Not verified An indie developer's companion app for Bluetooth glucose meters, unrelated to BEGAMOB, just shares the name Apple Health plus the official Dexcom/Libre apps Big-company features Years Built into the system or bundled with the device Free with real readings, but you need a glucose meter or CGM FaceVital (same developer) iOS 2026-06 US 1,257 ratings, 7 days +124 Face scanning for heart rate and stress; Glucera's Face Scan was very likely carried over from it (both share a privacy policy domain) - Where users come from
- Confirmed Facebook/Meta video ads: two dedicated Pages: "Glucera - Blood Sugar Monitor" (61594388334053) and "Glucera - Friendly Blood Sugar Monitor" (61593932737210); one Reel from 09-25 has 89k views and only 232 reactions; number of active ads not verified
- Confirmed Ad pitch: free, scan your face to get blood sugar: the Page's video summary says, verbatim: "free app that measures your glucose level instantly with your front camera. Stop pricking your fingers"; 10 of the 13 written US reviews are 1 stars, all saying the face-scan promise in the Facebook ad doesn't work and that it costs $9.99/week
- Confirmed Soft paywall on the first screen plus a face-scan demo video: ScreensDesign teardown: the paywall appears right after 12 onboarding steps, with a background video demoing the face scan, and only a weekly subscription option
- Confirmed In-app prompt for ratings: ScreensDesign: a custom rating prompt appears after the user's first logged reading; 1,018 ratings average 4.68, but only 13 have text, and most are 1 stars
- Inferred Store search keywords and category choice to avoid review: the title includes "Blood Sugar Tracker," the category is set to Lifestyle, the store description has a disclaimer, and the exaggerated claims only appear in the ads
- Confirmed Reusing a factory of apps: BEGAMOB launched FaceVital, Artera, and Glucera one after another from 2026 6 through August; US new ratings in their first 7 days were 124, 118, and 101, each localized into 33 languages with the same pricing
- Inferred TikTok/X/Reddit/press: x-radar shows 90 posts in the last 0 days; a TikHub search for "glucera" returns 0 videos; no press coverage
Glucera: Blood Sugar Tracker (ios_6796661353) research report
In one line: Vietnam's iKame, through BEGAMOB, applied the same playbook to "blood sugar." Facebook video ads say "free, scan your face with the front camera to check blood sugar, no finger pricks." Users install it, find it only logs readings manually, and get pushed by a first-screen paywall into a $6.99–9.99/week subscription. It grows because of paid acquisition and the paywall, not the product. The product itself is an ordinary blood sugar log with a "face scan" gimmick on top.
Regions checked: the appstore library was scanned across all storefronts (app_profile grouped by cc, 60–72 storefronts charted in total). The US store got a separate look at daily curves, snapshots, and the review RSS feed. We also checked the googleplay library, the metaads library, x-radar, and TikHub. Web searches used Jina, Exa, and Brave.
1. Basic data
- The developer is BEGAMOB GLOBAL LIMITED (bundle
com.begamob.bloodsugar), the publishing entity of iKame Global in Hanoi, Vietnam. The iOS launch was 2026-08-31, categorized as Lifestyle (secondary: Health & Fitness), current version 1.0.4 (2026-10-12), 121 MB, supports 33 languages. (iTunes lookup, 2026-11-06) - In-app purchases: Weekly Premium $9.99 / $6.99, Premium Yearly $49.99 / $39.99 / $29.99. (US App Store page, read via Jina)
- The store description only talks about logging, with a disclaimer attached: "The app does not measure, diagnose… Face Scan is provided as a wellness feature." The feature list says "Face Scan records." The privacy policy domain is
face-scan-privacy.begamob.com, shared with the same developer's face-scan app FaceVital. (lookup; App Store page) - Ratings: US 887 (10-28) → 1,018 (11-06), +131 over 9 days, 10–18 new ratings per day, average holding steady at 4.66–4.68. (appstore.app_snapshot / app_day) About 85% of the 1,203 global ratings come from the US, followed by Mexico 34, Australia 23, and the Philippines 18; every other country is in single digits. (appstore.app_profile, 2026-11-06)
- Charts: US Lifestyle Top Grossing ranks 55–75 (10-28 was 55, then it slowly slid to 11-06 in 75), never charted in overall. Data cards show ranks like #4 Lifestyle Top Grossing in the British Virgin Islands and #11 in Nepal. These only show that category charts in small countries have low bars (those storefronts have 0–2 ratings). They are not evidence of real revenue there. The money comes from the US.
- Android version:
com.begamob.bloodsugar"Glucera: Blood Sugar Log," developer iKame Applications - Begamob Global, listed in 2026-08-21. Cumulative installs for all of September were under 100; scaling suddenly from 10-02, reaching 3,599,11-06 by 10-03 as 49,602, with 7 days +12,362. (googleplay.app_profile / app_day_ext) The curve looks like it started scaling the moment budget went in: almost nobody installed in September, paid acquisition started in early October, and the numbers jumped.
2. Competitors
| Product | Platform | Launched | Scale (US 2026-11-06 within the library) | How it differs from Glucera | |
|---|---|---|---|---|---|
| Glucose \ | Blood Sugar Tracker(App Sub 1 LLC) | iOS | 2016-07 | 28.6k ratings, Medical Top Grossing for 25,7 days +19 | Long-running pure logging tool with no "scan to measure" gimmick, relies on organic search |
| mySugr(Roche) | iOS/Android | 2012-04 | 33.6k ratings, Medical Top Grossing for 50,7 days +80 | Medical device certification, connects to Roche glucose meters, medical backing | |
| Glucose Buddy(Azumio) | iOS | 2008-10 | 24.6k ratings | Established brand, also sells a subscription | |
| HealthPro: Blood Sugar(X-PIONEER/TickFlow) | iOS | 2026-03 | 2,778 ratings, 7 days +118, H&F Top Grossing 124 | Closest in approach: camera heart-rate reading and blood sugar logging, published by a Hong Kong shell company; rating growth about the same as Glucera | |
| RateTracker: Blood Sugar(X-SPARK HK) | iOS | 2025-06 | 5,645 ratings, +82 in 7 days | Same category, description says "measure heart rate with the phone and log blood sugar" | |
| Diabetes Tracker by MyNetDiary, Glucobyte, GLog, Nutrisense, and others | iOS | 2012–2020 | 2k–6k ratings | Legitimate logging or CGM companion tools, all with very low growth | |
| Blood Sugar - Diabetes App, Blood Sugar Care: BP Monitor, and others | Android | — | About 25M installs, 7 days +6–200k | The top same-category app on Android, several hundred times Glucera's scale | |
| Glucera (glucera.app, a separate app with the same name) | iOS | 2026-04 | Scale unverified | Connects to Bluetooth glucose meters and writes to Apple Health, no network; just a name collision, no relation to BEGAMOB | |
| Manual blood sugar logging in Apple Health plus the official Dexcom / Libre apps | Big-company features | Years | Built into the system or bundled with the device | Free with real readings, but you need a CGM or glucose meter | |
| FaceVital (same developer) | iOS | 2026-06 | 1,257 ratings, +124 in 7 days | Face scanning for heart rate and stress. Glucera's "Face Scan" was very likely carried over from it (both share a privacy policy domain) |
Bottom line: blood sugar logging is an old category, and it's already crowded. Glucera ranks around #15 in US rating count, but #2 for 7-day rating growth, behind only HealthPro, and ahead of mySugr and the older Glucose apps. The fast growth comes from paid acquisition, not organic demand.
3. Growth tactics
- Facebook / Meta video ads (confirmed). There are at least two dedicated Facebook Pages: "Glucera - Blood Sugar Monitor" (id 61594388334053) and "Glucera - Friendly Blood Sugar Monitor" (id 61593932737210). The first posted a Reel, "Blood Sugar Tracking Made Simple," on 2026-09-25 with 89k views, 232 reactions, and 16 comments; another posted on 10-22 has only 887 views. The second posted one on 11-01 with 764 views. Low engagement with high views suggests ad creative. (facebook.com pages, read via Jina) Neither Page is on our metaads tracking list, and the number of active ads is not verified.
- Ad hook: "Free + face scan for blood sugar + no finger pricks" (confirmed). Video summaries from two Facebook Pages surfaced by search engines contain these lines: "Sure, blood sugar is a free app that measures your glucose level instantly with your front camera. Stop pricking your fingers every day" / "The app analyze your blood sugar status instantly without finger pricks… The app is completely free" / "Simply point your phone's camera at your face to monitor your…" (Jina search result snippets). US store reviews match: 10 of the 13 written reviews are 1-star, with lines like "Facebook ad shows a picture of a person doing a face scan and it immediately provides a blood glucose level. None of his apps… will do that" / "No sugar reading as developer advertised in Facebook… Not worth 10$ a week" / "It says it's free, but it's not, it's $9.99 weekly" (App Store reviews RSS, 2026-09-25 to 10-29).
- Paywall design (confirmed). ScreensDesign's teardown: onboarding has 12 steps, then a "soft paywall" appears right after, with a full-screen video demoing the face scan behind it and only one weekly plan. (screensdesign.com/showcase) That connects the ad's promise to the payment point: users pay for "scan your face to check blood sugar," then find the face scan can't produce a glucose reading.
- Review prompting (confirmed). The same teardown says the "custom rating prompt (02:13) is well-timed after a successful core action": the first time a user logs a reading, the app shows its custom rating dialog. This explains the average of 4.68, and why the public written reviews are almost all 1 stars: only 13 of 1,018 ratings have text. The developer answers every negative review with the same line: "Glucera is designed for blood glucose journaling."
- Store search (inferred). The title "Blood Sugar Tracker" uses high-volume search terms. The Lifestyle category, rather than Medical or Health & Fitness, most likely avoids the strict review of medical measurement claims under Apple's App Review Guideline 1.4.1. The store copy stays conservative; the bold claims live only in the Facebook ads, not on the store page.
- Factory matrix reuse (confirmed). BEGAMOB shipped FaceVital (6-19, face-scan health), Artera (8-23, blood pressure) and Glucera (8-31, blood sugar) in a row from 2026 6 through August. Their US new ratings in the last ~7 days are 124, 118 and 101. All three are localized into 33 languages, use the same paywall prices, and run the same ad copy ("free, measure with your phone"). (appstore.app_profile; lookup) The older iCardiac (2023, 31k ratings) proved the model first.
- Channels not found: x-radar searches for "Glucera", "face scan blood sugar" and "Begamob" each returned 0 results over the last ~90 days; TikHub searches for "glucera" return 0 videos; there's no press or Reddit coverage specifically about Glucera (searching "Glucera" only turns up Abbott's nutrition drink Glucerna).
4. Why it took off
- Why users come: tens of millions of Americans have diabetes or prediabetes, and finger-stick glucose tests hurt and cost money. "Scan your face and get a reading, no finger pricks, and it's free" hits that pain point directly, and the target audience is middle-aged and older people who scroll Facebook video. PhoneArena wrote about Harmoni using the same pitch 2024 years ago, and TrendLife also reported a wave of fake "AI health scan" ads 2026-10-02, showing these claims convert and people keep using them.
- Why people pay: the first-screen paywall uses the face-scan video to push people into a $6.99–9.99/week subscription, and many subscribe without reading closely (reviews include "charging me after I asked to cancel"). A weekly subscription only needs each payer to stay 2–3 weeks for paid acquisition to pay back.
- How much money (third-party estimate, unverified): the data card lists monthly revenue of about $100k; ScreensDesign says "$210k/mo" in one place and "monthly revenue $35,000, 30k monthly installs" in another. Against US Lifestyle top-grossing ranks 55–75, thousands of dollars a day in revenue is plausible. The three figures differ by 6×, so treat them as an order-of-magnitude guide only.
- Why now: no platform event; it's iKame's routine expansion. After the same "health measurement → weekly subscription" model worked on heart rate (iCardiac) and blood pressure (Artera), they opened another package on the blood sugar topic. Android volume spiking 10-02 suggests paid acquisition ramped up from early October.
5. Differentiation
No real product differentiation. Features (manual logging of glucose, insulin, meds, weight; estimated A1C; reminders; report export) are fewer than established free tools offer. The only "difference" is a "Face Scan" feature that can't produce a glucose reading, which serves as a hook for ads and the paywall. What actually makes it work is:
- The ads say what the store page can't (scan your face for blood sugar, free), while the store page stays compliant and the Lifestyle category gets it through review;
- The paywall uses the face-scan video to connect the ad's promise to payment, and a prompt asking for a rating right after the first logged reading pushes the average to 4.7;
- Behind it is a factory that can churn out packages in 33 languages and run several Facebook Pages at once.
So its "differentiation" is this distribution and conversion playbook, and that's why it works. The product itself isn't what's doing the work.
6. Visibility
Few people know about it yet. No public revenue (only third-party estimates like ScreensDesign's), no media coverage specifically on it, and no discussion on X, TikTok or Reddit. What's visible is 1 App Store reviews, plus general Facebook diabetes-group posts asking "is the face-scan blood sugar app a scam?" But the playbook itself has been public for a while (PhoneArena 2024, TrendLife 2026-10, Diabetes Victoria's Australian warnings), and many in this niche run the same play.
7. Copycats
No one is specifically tracking Glucera. Contemporaries using the same play include HealthPro: Blood Sugar (X-PIONEER HK, +118 in 7 days), RateTracker (X-SPARK HK), and MyVitalTrack (Beijing Qimai Xingqiu, 2026-09-08 listed, currently running Meta video ads for "record blood pressure, blood oxygen and blood sugar"); its sibling apps FaceVital and Artera use the same playbook.
8. What to borrow
- Once the "topic → new package → same creative and paywall" model works, it can be copied across health anxieties one by one (heart rate → blood pressure → blood sugar);
- The paywall shows the "most-wanted feature" in a demo video and offers only a weekly subscription;
- A custom rating dialog appears right after the user completes the first core action, keeping the average above 4.5 to offset negative reviews;
- What not to copy: claiming "face scan for blood sugar" in ads is false medical advertising. The FTC penalized a similar blood pressure app 2016 years ago, Apple 1.4.1 could pull it any time, and refund and chargeback risk is high. Dial the claims back and reposition as "log + remind + report" if you want a version that lasts.
9. Still unclear
- How many ads the two Facebook Pages run, the budget, and whether they also use Google UAC or US TikTok (none verified);
- Real revenue: third-party estimates range from $35k to $210k/month; trial-to-paid conversion and renewal rates are unknown;
- What the "Face Scan" actually outputs in the app (possibly PPG-based estimates like heart rate or stress, or nothing at all). I haven't installed the app to test it;
- Whether Apple will act on the mismatch between the ad and the product.
Sources
- iTunes lookup:itunes.apple.com/lookup?id=6796661353&country=us(2026-11-06)
- App Store page (in-app purchases, privacy): apps.apple.com/us/app/glucera-blood-sugar-tracker/id67966613…
- Review RSS: itunes.apple.com/us/rss/customerreviews/id=6796661353/sortBy…
- Facebook Page / Reel:www.facebook.com/61594388334053/videos/blood-sugar-tracking-… ;www.facebook.com/61594388334053/videos/understand-your-numbe… ;www.facebook.com/61593932737210/videos/blood-sugar-tracking-…
- ScreensDesign:screensdesign.com/showcase/glucera-blood-sugar-tracker ;screensdesign.com/apps/glucera-blood-sugar-tracker/
- Android: play.google.com/store/apps/details?id=com.begamob.bloodsugar; googleplay library (app_profile, app_day_ext)
- Namesake Glucera: glucera.app/
- Coverage of the same play: www.phonearena.com/news/this-is-the-biggest-scam-in-the-app-… (2024-08); trendlife.com/en-us/blog/2026/10/02/ai-health-scan-ad-fake-a…; www.diabetesvic.org.au/scam-advertisements-for-glucose-monit…
- Same developer's Artera report: /home/ljr/fanout/why/out/ios_6791480852.md
- Internal libraries: appstore (app_profile, app_day, app_snapshot, app), googleplay (app_profile, app_day_ext), metaads (advertiser, ad), x-radar, TikHub; query date 2026-11-06